Results 231 to 240 of about 42,047 (260)
Some of the next articles are maybe not open access.
Seminars in Thrombosis and Hemostasis, 2019
AbstractThe activated partial thromboplastin time (APTT) assay is a very common coagulation test, used for several reasons. The test is conventionally used for assessing the contact factor (intrinsic) pathway of blood coagulation, and thus for screening deficiencies in this pathway, most typically factors VIII, IX, and XI. The APTT is also sensitive to
Favaloro, Emmanuel J +3 more
openaire +2 more sources
AbstractThe activated partial thromboplastin time (APTT) assay is a very common coagulation test, used for several reasons. The test is conventionally used for assessing the contact factor (intrinsic) pathway of blood coagulation, and thus for screening deficiencies in this pathway, most typically factors VIII, IX, and XI. The APTT is also sensitive to
Favaloro, Emmanuel J +3 more
openaire +2 more sources
International Journal of Medical Science and Public Health, 2016
Background: In recent times, growing coagulation test volume and constricted personnel budgets have enhanced interest in automated coagulation analyzers. Objective: (i) To compare the reliability of routine coagulation test [prothrombin time (PT) and activated partial thromboplastin time (APTT)] using mechanical, photo-optical, and nephelemetric ...
Nitinkumar Rathod +3 more
openaire +1 more source
Background: In recent times, growing coagulation test volume and constricted personnel budgets have enhanced interest in automated coagulation analyzers. Objective: (i) To compare the reliability of routine coagulation test [prothrombin time (PT) and activated partial thromboplastin time (APTT)] using mechanical, photo-optical, and nephelemetric ...
Nitinkumar Rathod +3 more
openaire +1 more source
APTT: A screening test for hypercoagulability in type 2 diabetes mellitus patients
Medical Journal of Zambia, 2014Background: Thrombosis is a common complication in Type 2 Diabetes Mellitus (T2DM). Prolonged APTT values have clinical relevance as an indicator of factor deficiency or the presence of coagulation inhibitors. However, there is mounting evidence that shortened APTT values in some cases may reflect a hypercoagulable state, which is potentially ...
Mwambungu, A +4 more
openaire +1 more source
Thrombosis Research, 2014
Lupus anticoagulant (LA) is an antibody that interferes with one or more in vitro coagulation reactions, which are dependent on interactions with protein-phospholipid complexes. For LA diagnosis, a mixing test is considered useful for differentiating the inhibitor from a factor deficiency.
Osamu, Kumano +6 more
openaire +2 more sources
Lupus anticoagulant (LA) is an antibody that interferes with one or more in vitro coagulation reactions, which are dependent on interactions with protein-phospholipid complexes. For LA diagnosis, a mixing test is considered useful for differentiating the inhibitor from a factor deficiency.
Osamu, Kumano +6 more
openaire +2 more sources
Coagulation Testing: Looking Beyond the PT and aPTT
2023Mark T. Friedman +5 more
openaire +1 more source
Determining the cutoff value of the APTT mixing test for factor VIII inhibitor
Clinical Chemistry and Laboratory Medicine (CCLM), 2019Ning, Tang +3 more
openaire +2 more sources
DTW. Deutsche tierarztliche Wochenschrift, 1993
The factor VIII:C-sensitivity of the aPTT in dogs was investigated for 2 different, commercially available reagents. For this purpose, 45 plasmas with a decreased factor VIII:C-activity, which were collected from haemophilic dogs (n = 10) at variable points of time of a substitution therapy were used.
openaire +1 more source
The factor VIII:C-sensitivity of the aPTT in dogs was investigated for 2 different, commercially available reagents. For this purpose, 45 plasmas with a decreased factor VIII:C-activity, which were collected from haemophilic dogs (n = 10) at variable points of time of a substitution therapy were used.
openaire +1 more source
The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies
International Journal of Laboratory Hematology, 2011A E Bowyer +2 more
exaly

